What are the circumstances where a company is obligated to tell the government about safety-related issues related to their products according to the Food and Drug Administration (FDA)?
Companies are obligated to report safety-related issues to the FDA when there is a link between a product they imported or distributed and a consumer’s illness. This obligation arises when there is a safety issue that could be classified as a class one recall, which includes situations like bacterial contamination or severe chemical poisoning that can cause illness or death. Importers or distributors must have systems in place to handle consumer complaints and assess whether the problem falls under FDA’s class one recall category.
How does the obligation to report safety-related issues differ between FDA and customs enforcement?
While the FDA mandates reporting of safety-related issues, there is no regulatory requirement for importers to report mistakes related to FDA requirements. In contrast, customs enforcement requires reporting if there are errors in customs declarations that involve issues like duty or intellectual property. Customs has specific procedures for prior disclosures to address mistakes in customs declarations, unlike the FDA, which does not have a voluntary disclosure system.
In what situations can a voluntary disclosure reduce risk, and when might it create additional exposure for a company?
Voluntary disclosures can reduce risk when a company proactively reports mistakes, such as misdeclarations in customs that could lead to penalties if discovered later. In cases like duty errors, prior disclosures can prevent penalties but not duty payment. However, voluntary disclosures can create additional exposure if a company fails to disclose issues like duty misdeclarations that customs could detect through investigations, potentially leading to penalties, interest, and duty repayments with added costs.
What types of issues are suitable for voluntary disclosure in the FDA space, and when might a different strategy be more appropriate?
In the FDA space, issues like products on import alert that need further examination or root cause analysis benefit from voluntary disclosure to maintain compliance and demonstrate corrective actions. However, when it comes to customs issues, like misdeclarations affecting duty under a free trade agreement, careful consideration is needed to determine whether voluntary disclosure is necessary to avoid penalties and potential investigations that could unearth long-standing errors. Cultural differences and risk tolerance among companies also play a role in decision-making regarding voluntary disclosures.
If you’re facing challenges with importing FDA-regulated products, we’re here to help you navigate the process smoothly. Let us be your guide through the complexities of trade tariffs, FDA compliance, and border issues. Visit us at FDAImports or contact us directly at contact@fdaimports.com for assistance.
This news update is provided for informational and educational purposes only and does not constitute legal advice and is not intended to form an attorney-client relationship. Please contact your regular FDAImports representative for additional information.
